High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients.
about
Voriconazole-associated cutaneous malignancy: a literature review on photocarcinogenesis in organ transplant recipientsCutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease.The 7th edition AJCC staging system for cutaneous squamous cell carcinoma accurately predicts risk of recurrence for heart and lung transplant recipients.Voriconazole Exposure and Risk of Cutaneous Squamous Cell Carcinoma, Aspergillus Colonization, Invasive Aspergillosis and Death in Lung Transplant Recipients.Lung transplantation for cystic fibrosis: results, indications, complications, and controversies.Voriconazole and its clinical potential in the prophylaxis of systemic fungal infection in patients with hematologic malignancies: a perspective reviewPhotosensitizing medications and photocarcinogenesis.Adverse effects of voriconazole: Over a decade of use.Complications of invasive mycoses in organ transplant recipients.Lung transplantation for cystic fibrosis: an update.Basic aspects of the pathogenesis and prevention of non-melanoma skin cancer in solid organ transplant recipients: a review.High-risk cutaneous squamous cell carcinoma in a Japanese allogeneic bone marrow transplant recipient on long-term voriconazole.Recurrent and metastatic squamous cell carcinoma in lung transplant recipient on voriconazole: Lessons learned.Voriconazole and squamous cell carcinoma after lung transplantation: a multicenter study.Clinical considerations in the early treatment of invasive mould infections and disease.Effect of voriconazole on risk of nonmelanoma skin cancer after hematopoietic cell transplantation.Voriconazole increases the risk for cutaneous squamous cell carcinoma after lung transplantation.Exposure to moxifloxacin and cytomegalovirus replication is associated with skin squamous cell carcinoma development in lung transplant recipients.Practice variation in Aspergillus prophylaxis and treatment among lung transplant centers: a national survey.Autosomal Dominant Hyper-IgE Syndrome in the USIDNET Registry.Aspergillosis in solid organ transplantation.Risk-adjusted relationship between voriconazole utilization and non-melanoma skin cancer among lung and heart/lung transplant patients.Voriconazole N-oxide and its ultraviolet B photoproduct sensitize keratinocytes to ultraviolet A.Voriconazole exposure and the risk of cutaneous squamous cell carcinoma in allogeneic hematopoietic stem cell transplant patients.[Phototherapy and carcinogenesis].Voriconazole-induced photosensitivity: photobiological assessment of a case series of 12 patients.Voriconazole-induced photocarcinogenesis is promoted by aryl hydrocarbon receptor-dependent COX-2 upregulation.Squamous cell carcinoma of the skin and voriconazole therapy in lung transplant recipients: a case seriesA Multistep Voriconazole-Related Phototoxic Pathway May Lead to Skin Carcinoma: Results From a French Nationwide Study
P2860
Q27012442-B4D070CC-A27E-47B9-B0B6-347D334CE849Q30249213-1F18E79F-2B00-44B6-B4DC-48606DDEB78AQ35936988-D9965F31-32A1-4D3E-8EDC-9C7888404DE3Q36480011-AC70E0DE-5406-4870-B1C5-D34612FD76D3Q36658777-CBD82AA4-CCB3-4319-A50D-B1428B5C1D37Q38111391-65D06661-E944-4E40-A379-3F53CD9D50D4Q38176091-CDC0C2CB-5E8A-4ED1-B3CA-A7DB569F2937Q38942862-59D41B68-03FF-404B-B248-3CC0FE7565C9Q38969056-10B2EFCF-DFE0-4D91-8392-3634A75EE10AQ39008114-2D4A6C43-3A47-4747-A18A-74C34A5DD04CQ39015006-63C0CD8C-0E9F-4C63-8BCF-1657838A8DC0Q39282722-6C6CC678-0C41-4EF4-AE6F-80F8D887A249Q39564953-7DB80833-3BB6-4DDE-86C8-1EED37CF1298Q40051243-5151043D-A39C-4BA2-A73D-0B120AADC588Q40063394-A76DD227-D03F-43B3-8F4F-894F944BE9A4Q40093479-682105BC-64F2-4715-A8AC-BDA3AD760870Q40491238-8A93E06F-2AFA-4529-82DE-059971D8976CQ40983397-C64E2C86-1F50-4089-AA78-FB12741B27D9Q41522687-2DC67CF1-4C1F-48F1-BDE5-56F855A9B46EQ41995130-E9B0A9D7-A0FD-4D9E-8401-0FF3B9D23045Q42272291-28EADC21-A9E1-4D19-8660-54EA2DE7CBD5Q42435668-32680A61-B050-4FAC-907A-EA3CCE062F8AQ43123661-CE9D514D-9653-4CD2-949A-0D905B482782Q45227924-758263D6-B75D-4458-9CBC-5E5200EF6359Q53254939-2C949C05-8C6A-4F04-9E89-E009C2553BB9Q53266683-7964A7F5-20E0-4E23-B59B-30F5978B650DQ55162562-0C717C56-716D-4E51-9FAF-7151F2BF7165Q57746013-4C5C8562-2669-4B64-A419-263248FE5869Q57779700-D2692C05-78C2-4212-ABAB-8D088A9AE497
P2860
High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
High cumulative dose exposure ...... in lung transplant recipients.
@ast
High cumulative dose exposure ...... in lung transplant recipients.
@en
type
label
High cumulative dose exposure ...... in lung transplant recipients.
@ast
High cumulative dose exposure ...... in lung transplant recipients.
@en
prefLabel
High cumulative dose exposure ...... in lung transplant recipients.
@ast
High cumulative dose exposure ...... in lung transplant recipients.
@en
P2093
P2860
P1476
High cumulative dose exposure ...... in lung transplant recipients.
@en
P2093
Andreas Boker
Christopher Metchnikoff
David V Glidden
Jeffrey A Golden
Jonathan P Singer
Maxwell Binstock
Rebecca Boettger
Sarah T Arron
P2860
P304
P356
10.1016/J.HEALUN.2012.02.033
P577
2012-04-06T00:00:00Z